Abstract
Interleukin-10 (IL-10) is a major immunoregulatory cytokine and has a multitude of immunomodulatory effects in the immune system. In this study, we have examined the secretion andin vitro function of IL-10 in B cell hyperactivity in antibody production in two common autoimmune diseases, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). IL-10 was detectable in serum of all active SLE and serum and synovial fluid samples of all RA patients but in none of the normal controls. B cells and CD4+CD45RO+ “memory” T cells secreted highly enhanced levels of IL-10 in SLE and RA versus normals. Increased IgM and IgG production by B cells-CD4+CD45RO+ T cells in SLE and RA was IL-10 dependent, since neutralization of IL-10 cytokine by anti-IL-10 antibody drastically reduced Ig synthesis in these coculture experiments. B cell hyperactivity in autoantibody production in SLE and RA may be a function of IL-10-dependent CD4+CD45RO+ Th2 cell activation. Therefore, IL-10 may play an important role in highly disturbed immune system and B cell-T cell function in these immune disorders.
Similar content being viewed by others
References
Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse helper T cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2089, 1989
O'Gara A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H, Barbis D, Stall A, Cupp J, Moore K, Vieira P, Mosmann T, Whitmore A, Arnold L, Haugton G, Howard M: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2:821–832, 1990
de Waal MR, Abrams J, Bennett B, Figdor C, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes. An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220, 1991
Fiorentino DF, Zlotnik A, Mossmann TR, Howard M, O'Gara A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822, 1991
Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick D: Interleukin-10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507–510, 1991
Zlotnik A, Moore KW: Interleukin-10. Cytokines 3:366–371, 1991
Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ. IL-10 mediates susceptibility to trypanosoma cruzi infection. J Immunol 153:3135–3140, 1994
Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell derived cytokine. Annu Rev Immunol 10:385–399, 1992
Howard M, O'Garra A, Ishida H, de Waal MR, de Vries J: Biological properties of interleukin-10. J Clin Immunol 12:239–247, 1992
Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165–190, 1993
Hahn BH: An overview of the etiology and pathogenesis of systemic lupus erythematosus.In Systemic Lupus Erythematosus, 4th ed, Wallace, Hahn (eds). Philadelphia, Lea & Fibger, 1992, pp 65–70
Paget SA, Gibofsky A: Immunopathogenesis of rheumatoid arthritis. Am J Med 67:961–970, 1979
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systmic lupus erythematosus. Arth Rheum 25:1271–1277, 1982
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315–324, 1988
Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S: Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis. J Rheumatol 20:1647–1653, 1993
Al-Janadi M, Raziuddin S: B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885–1891, 1993
Klinman DM: B cells.In Steinberg AD, moderator. Systemic lupus erythematosus. Ann Intern Med 115:550–555, 1991
Ueda Y, Sakane T, Tsunematsu T: Hyperactivity of activated B cells to B cell growth factor in patints with systemic lupus erythematosus. J Immunol 143:3988–3993, 1989
Raziuddin S, Al-Janadi M, Al-Wabel AA: Soluble interleukin-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestation of the disease in patients with systemic lupus erythematosus. J Rheumatol 18:831–836, 1991
Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR: Elevated levels of endogeneous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123, 1991
Hochberg MC: Systemic lupus erythematosus. Rheum Dis Clin North Am 16:613–639, 1990
Raziuddin S, Nur MA, Al-Wabel AA: Selective loss of the CD4+ inducers of T cell subsets (2H4) in active systemic lupus erythematosus. J Rheumatol 16:1315–1319, 1989
Morimoto C, Romain PL, Fox DA, Schlossman SF: Abnormalities in CD4+ T lymphocyte subsets in inflammatory rheumatic diseases. Am J Med 84:817–825, 1988
Emery P, Gentry KC, Makay IR, Muirden KD, Rowley M: Deficiency of the suppressor-inducer subsets of T lymphocytes in rheumatoid arthritis. Arth Rheum 30:849–856, 1987
Morimoto C, Steinberg AD, Letvin NL, Fox DA, Romain PL, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated by anti-2H4 antibody. J Clin Invest 79:762–768, 1987
Horwitz DA, Wang HA, Gray JD: Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: Increased interleukin-2 but not interleukin-4 mRNA. Lupus 3:423–428, 1994
Zagon G, Tumang JR, Li Y, Friedman ST, Crow MK: Increased frequency of Vb17-positive T cells in patients with rheumatoid arthritis. Arth Rheum 37:1431–1440, 1994
Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Smolen J, Graninger WB. High levels of bcl-2 protein in circulating lymphocytes but not B lymphocytes of patients with systemic lupus erythematosus. Arth Rheum 37:1423–1430, 1994
Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC: serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 82:2169–2174, 1993
Smilie D, Touitou R, Raphel M, Peuchmaur M, Devergnee O, Rea D, Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937–2942
Baiocchi R, Ross ME, Tan JC, Chou CC, Sulivan L, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundent production of human interleukin-10. Blood 85:1063–1074, 1995
Katsikis PD, Chu CQ, Brenan FM, Mainin RN, Feldmann M. Immunoregulatory role in interleukin-10 in RA. J Exp Med 179:1517–1521, 1994
Taga K, Chernay B, Tosato G: IL-10 inhibits apoptic cell death in humans T cells starved of IL-2. Int Immunol 5:1599–1604, 1993
Cohen SB, Katsikis PD, Feldmann M, Londei M: IL-10 enhance expression of the IL-2 receptorα chain on T cells. Immunology 83:329–332, 1994
MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:4167–4172, 1990
Via CS, Handwerger BS: T cell and B cell function in lupus. Curr Opinion Rhumatol 4:630–634, 1992
Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptic death of Ly 1 (CD5+) B cells responsible for autoimmune disease in transgenic mice. Nature 357:77–80, 1992
O'Gara A, Chang R, Hastings R, Go N, Haughton G, Howard M: Ly1B (B1) cells are the main source of B cell derived IL-10. Eur J Immunol 22:711–717, 1992
Ishida H, Hastings R, Kearney J, Howard M: Continuous anti-IL-1 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175:1213–1220, 1992
Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305–310, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Janadi, M., Al-Dalaan, A., Al-Balla, S. et al. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol 16, 198–207 (1996). https://doi.org/10.1007/BF01541225
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01541225